Proxyanalyst LogoProxyanalyst
CompaniesSpecial SituationsExplorerAbout
Terms and Conditions & Privacy PolicyHoryzen LLCSitemap

AMNEAL PHARMACEUTICALS INC CLASS A (AMRX)

Sector: Health Care

ExecutivesDirectorsTrendsAnnual MeetingProxy Filings
  1. Home
  2. Companies
  3. AMNEAL PHARMACEUTICALS INC CLASS A

Board of Directors

Director information for AMNEAL PHARMACEUTICALS INC CLASS A (data for year 2026)

NamePositionAgeQualifications and ExperienceCommittee MembershipsFiling Year
Chintu PatelCo-Chief Executive Officer, Director54["CEO, General Management, Commercial", "Manufacturing", "R&D, Scientific", "Regulatory"][]2026
Chirag PatelCo-Chief Executive Officer and President, Director59["CEO, General Management, Commercial", "Corporate Development, Business Development, M&A", "Investment, Venture Capital", "International", "Regulatory"][]2026
Deb AutorChief Policy Officer; Director59["General Management", "Biosciences, Pharmaceuticals", "Regulatory", "Compliance", "Legal"][]2026
Gautam PatelBoard Member; Director53["Managing Director of Tarsadia Investments", "Led financial and strategic advisory efforts at Lazard", "Experience in M&A", "Knowledge of the Company\u2019s business and operations", "Deep experience in finance, corporate development, and healthcare investing"][]2026
Jeff GeorgeManaging Partner; Director52["CEO, General Management, Commercial", "Corporate Development, Business Development, M&A", "Investment, Private Equity", "International"][]2026
J. Kevin BuchiChair; Director70["CEO, General Management, Commercial", "Corporate Development, Business Development, M&A", "Finance and Accounting", "International"]["remuneration and nominating committee", "audit committee"]2026
John KielyChair; Director67["General Management", "Commercial", "Finance and Accounting", "M&A", "International"][]2026
Paul MeisterChairman of the Board of Directors73["CEO, General Management, Commercial", "Corporate Development, Business Development, M&A", "R&D, Scientific", "Investment, Venture Capital", "International"][]2026
Shlomo YanaiBoard Member; Director73["Former President and CEO at Teva Pharmaceutical Industries Ltd.", "Former CEO of Adama Industries", "Chairman of the Board of Lumenis Ltd.", "Senior advisor to Moelis & Company", "Various leadership positions in the Israel Defense Forces", "Graduate of Harvard Business School\u2019s AMP program", "Master of Public Administration from George Washington University", "B.A. degree from Tel Aviv University"][]2026
Ted NarkChairman of West Edge Partners; Director67["CEO", "General Management", "Commercial", "Corporate Development", "Business Development", "M&A", "Investment", "Venture Capital", "International"][]2026